Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress
Independent valuation of PsyLabs values Psyence Biomed’s stake at approximately $2 million, doubling in value Debt-for-equity swap with Psyence Group...
Pharmaceutical
Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction
SOUTH SAN FRANCISCO, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that COMET-HF (Confirmation of...
Pacira Awarded New U.S. Patent Covering EXPAREL Composition
-- First in new family of EXPAREL patents -- -- Expands EXPAREL intellectual property and provides protection into 2044 -- PARSIPPANY,...
Defence Provides Update on Delivery of AGSM Proxy Materials
Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
TransMedics Appoints Gerardo Hernandez as Chief Financial Officer and Provides Updated 2024 Financial Outlook
ANDOVER, Mass., Dec. 2, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming...
Jaguar Health Participating in December 3-5 Pet Connect Conference with Goal of Identifying Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for...
WCG Welcomes Industry Veteran Stacey Yount as Chief Growth Officer to Drive Long-Term Strategy and Expansion
PRINCETON, N.J., Dec. 2, 2024 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical...
AI in Precision Medicine Market to Hit US$ 3.92 Billion by 2030 with 30.7% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Dec. 2, 2024 /PRNewswire/ -- The global AI in precision medicine market is projected to reach USD...
Movano Health Receives FDA Clearance for EvieMED Ring
Company's first 510(k) clearance unlocks a TAM of $40 billion in healthcare B2B opportunities PLEASANTON, Calif., Dec. 2, 2024 /PRNewswire/...
IntegriChain and Blue Fin Group Pharma Distribution Experts to Speak at Informa Trade & Channel Strategies
Bill Roth's Keynote to Explore Access and Channel Complexities in 2024 and 2025 PHILADELPHIA, Dec. 2, 2024 /PRNewswire/ -- IntegriChain,...
Blue Matter Hires New Partner, Deepak Veeraraghavan, Expanding Capabilities in Decision Science
NEW YORK and DÜSSELDORF, Germany, Dec. 2, 2024 /PRNewswire/ -- Blue Matter is pleased to announce that Deepak Veeraraghavan has joined...
AG Mednet Releases AI-Assisted Redaction Capabilities in Judi Platform, Driving Regulatory Compliance in Clinical Trials
BOSTON, Dec. 2, 2024 /PRNewswire/ -- AG Mednet, a leader in clinical trial workflow and process automation, is excited to announce...
Segmed’s real-world imaging data solution to be integrated into Bayer platform to accelerate the development of AI-powered healthcare solutions
Segmed's 100 million imaging studies will help power the new AI innovation platform from Bayer in Radiology, enabling organizations to build AI-powered...
New Updates in Oracle Life Sciences Empirica Streamline Safety Signal Management Compliance in the Cloud
Multisource signaling across proprietary and public safety databases, including JADER, enables sophisticated data mining and GVP-compliant signal tracking globally AUSTIN,...
Bausch Health Appoints New Chief Medical Officer and Head of R&D
LAVAL, QC / ACCESSWIRE / December 2, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce the appointment...
Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma
FORT LAUDERDALE, FL / ACCESSWIRE / December 2, 2024 / Sunshine Biopharma Inc. (NASDAQ:"SBFM") (the "Company"), a pharmaceutical company offering...
Mapi Pharma is Seeking New Depot Product Partnerships
Management to Participate in 7th Annual Evercore HealthCONx ConferenceNESS ZIONA, Israel, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd.,...
Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
Healthy Extracts expands order after high demand for Gelteq’s collagen and Mynus sugar blocker gelsNEW YORK, Dec. 02, 2024 (GLOBE...
NovelMed Receives FDA IND Approval for NM8074 (Ruxoprubart), the First Anti-Bb Alternative Pathway Blocker for Treating Primary Immunoglobulin A Nephropathy (IgAN): A Renal Disorder
--- The United States FDA Clears Initiation of a Phase II Efficacy Trial in Immunoglobulin A Nephropathy (IgAN) Patients: a...
Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer...